Skip to content
← Late Effects of Treatment for Childhood Cancer (PDQ®)

FOR PATIENTS · SOURCE READING

Treatment that affects the hypothalamus or pituitary gland increases the risk of neuroendocrine system late effects.

Source: Late Effects of Treatment for Childhood Cancer (PDQ®)–Patient Version, National Cancer Institute.

Source updated: February 12, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.

Childhood cancer survivors have an increased risk for neuroendocrine late effects. These effects are caused by radiation therapy to treat cancer in the brain near the hypothalamus or used as total-body irradiation before a stem cell transplant. The hypothalamus controls the way hormones are made and released into the bloodstream by the pituitary gland. These effects are also caused by surgery in the area of the hypothalamus, pituitary gland, or optic pathways.

Source links and citations

Preserved source evidence · Independent clinical review pending · Not medical advice